2024
Julie van Krimpen Mortensen, Simona Mattiussi, Lars Hvass, Emilie Graae Lund, Vladimir Shalgunov, Frank Roesch, Umberto Maria Battisti, Matthias Manfred Herth, and Andreas Kjaer. [68Ga]Ga-DOTAGA-Glu(FAPi)2 Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging. Diagnostics 2024; 14(18):2024. DOI: doi.org/10.3390/diagnostics14182024. Open Access
Tilman Läppche ,Adrianna Bilinska, Eirinaios Pilatis, Elena Menéndez, Surachet Imlimthan, Euy Sung Moon , Ali Afshar-Oromieh, Frank Rösch, Axel Rominger and Eleni Gourni. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2. Molecules. 2024; 29(13):3093. DOI: doi.org/10.3390/molecules29133093. Open Access
Hugo Boutier, Liliana R. Loureiro, Lydia Hoffmann, Claudia Arndt, Tabea Bartsch, Anja Feldmann and Michael P. Bachmann. UniCAR T-Cell Potency—A Matter of Affinity between Adaptor Molecules and Adaptor CAR T-Cells? International Journal of Molecular Sciences. 2024; 25(13):7242. DOI: doi.org/10.3390/ijms25137242. Open Access